期刊文献+

帕金森病认知功能障碍相关标志物研究进展

Research progress on biomarkers related to cognitive dysfunction in Parkinson's disease
下载PDF
导出
摘要 帕金森病(PD)是最常见的运动障碍,认知功能障碍是PD中一种常见的非运动症状。PD认知功能障碍分为PD轻度认知障碍和PD痴呆,PD轻度认知功能障碍是介于PD认知功能正常和PD痴呆之间的阶段。认知功能障碍将严重影响患者生活质量,因此如何筛查高风险认知功能障碍的PD患者以早期进行监测和干预至关重要。本文就PD认知功能障碍相关标志物研究进展进行文献综述。 Parkinson's disease(PD)is the most common movement disorder,and cognitive dysfunction is a common non-motor symptom in PD.PD cognitive dysfunction is divided into mild cognitive impairment in PD and dementia in PD,and mild cognitive impairment is a stage between normal cognitive function and dementia in PD.Cognitive dysfunction will seriously affect patients'quality of life,so it is crucial to screen for PD patients at high risk of cognitive dysfunction for early monitoring and intervention.This artical provides a literature review on the progress of research on markers related to cognitive dysfunction in PD.
作者 史琳 叶民 SHI Lin;YE Min(Department of Neurology,the Affiliated BenQ Hospital of Nanjing Medical University,Nanjing 210019,China)
出处 《临床神经病学杂志》 CAS 2024年第5期387-392,共6页 Journal of Clinical Neurology
关键词 帕金森病 认知障碍 标志物 Parkinson's disease cognitive dysfunction maker
  • 相关文献

参考文献7

二级参考文献52

  • 1Litvan I, Goldman J, Tr6ster A, et al. Diagnostic criteria for mild cognitive impairment in Parkinsont s disease: Movement Disorder Society Task Force Guidelines[J]. Mov Disord, 2012, 27(3) : 349-356.
  • 2Muslimovic D,Post B, Speelman JD, et al. Cognitive profile of patients with newly diagnosed Parkinson disease [J]. Neurology, 2005,65(8) : 1239-1245.
  • 3Pedersen KF, Larsen JP, Tysnes OB, et al. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian Park West study[J]. JAMA Neurol, 2013,70 ( 5 ): 580-586.
  • 4Williams-Gray CH, Mason SL, Evans JR, et al. The CamPaIGN study of Parkinsons disease: 10-year outlook in an incident population-based cohort [ J ] . Neurol Neurosurg Psychiatry, 2013,84(11) :1258-1264.
  • 5Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of ParkinsonI s disease: the inevitability of dementia at 20 years[J]. Mov Disord,2008,23(6):837-844.
  • 6Yarnall A J, Breen DP, Duncan GW, et al. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study[J]. Neurology,2014,82(4) :308-316.
  • 7Compta Y, Marti MJ, Ibarretxe-Bilbao N, et al. Cerebrospinal tau phospho-tau, and 13-amyloid and neuropsychological functions in Parkinson' s disease [J]. Mov Disord, 2009, 24 (15) :2203-2210 .
  • 8Hall S,Ohrfelt A,Constantinescu R,et al. Accuracy of a panel of cerehrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders[J]. JAMA Neurol,2012,69(11) : 1445-1452.
  • 9Aires G, Brnnick K, Aarsland D, et al. CSF amyloid- and tau proteins, and cognitive performance, in early and untreated Parklnson's disease: the Norwegian Park West study[J]. Neurol Neurosurg Psychiatry, 2010,81(10) : 1080-1086 .
  • 10Alves G, Lange J, Btennow K, et al. CSF A1342 predicts early- onset dementia in Parkinson disease[J]. Neurology, 2014,82 (20) : 1784-1790.

共引文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部